PERIPHAGEN
PeriphaGen is a biopharmaceutical company whose corporate objective is the development of first in class neuronal gene delivery products for neurologic disorders with significant unmet medical need. The intuitive way to treat conditions that directly affect neurons is to target treatment to the neurons themselves. PeriphaGen's first indications of interest are neuropathic pain, neuropathy, and neuronal regeneration. The PeriphaGen NEuronal Therapeutics (NET) platform based drug candidates hav... e the ability to express therapeutic proteins directly and specifically in neurons for four to eight weeks after a simple intradermal application. NET products express natural gene products locally that block pain signaling, protect against neuronal damage, or promote neuronal regeneration without systemic side effects.
PERIPHAGEN
Industry:
Biotechnology Genetics Medical Device Pharmaceutical
Founded:
2012-01-01
Address:
Pittsburgh, Pennsylvania, United States
Country:
United States
Website Url:
http://www.periphagen.com
Total Employee:
1+
Status:
Active
Contact:
(412)488-0348
Email Addresses:
[email protected]
Total Funding:
6.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Content Delivery Network Euro GStatic Google Static Content Wix
Similar Organizations
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Dnaprint Genomics
DNAPrint Genomics is a genetics company with a wide range of products related to genetic profiling, forensic & consumer genomics products.
NewBridge Pharmaceuticals
Newbridge Pharmaceuticals is a pharmaceutical and medical device company engaged in developing oncology and supportive care products.
Sebela Pharmaceuticals
Sebela is committed to improving patients’ lives by developing, marketing and selling differentiated branded prescription pharmaceuticals.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.periphagen.com
- Host name: ec2-54-243-138-215.compute-1.amazonaws.com
- IP address: 54.243.138.215
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "PeriphaGen"
Periphagen
Periphagen is a biopharmaceutical company focused on the development of herpes simplex virus type I (HSV-1) as a gene therapy vector. Our primary focus is the use of HSV-1 vectors for …See details»
PeriphaGen - Crunchbase Company Profile & Funding
PeriphaGen is a biopharmaceutical company whose corporate objective is the development of first in class neuronal gene delivery products for neurologic disorders with significant unmet …See details»
PeriphaGen Inc - LinkedIn
PeriphaGen is a biopharmaceutical company focused on peripheral nerve gene therapy and committed to the development of innovative products for difficult-to-treat neurological disorders …See details»
OUR TEAM - periphagen
Prior to founding PeriphaGen Dr. Krisky was the Senior Director of Medical Science and Clinical Safety for Diamyd Incorporated and was responsible for the product development and clinical …See details»
Periphagen Company Profile - Craft
Periphagen is a biopharmaceutical company focused on peripheral nerve gene therapy for disorders such as neuropathy and chronic pain. It provides a Neuronal Therapeutics (NET) …See details»
PeriphaGen Company Profile 2024: Valuation, Investors
PeriphaGen General Information Description. Operator of a biopharmaceutical company headquartered in Pittsburgh, Pennsylvania. The company develops gene-delivery products to …See details»
PeriphaGen - Contacts, Employees, Board Members, Advisors
PeriphaGen is a biopharmaceutical company whose corporate objective is the development of first in class neuronal gene delivery products. Search Crunchbase. Start Free Trial . Chrome …See details»
PeriphaGen - Funding, Financials, Valuation & Investors
PeriphaGen is a biopharmaceutical company whose corporate objective is the development of first in class neuronal gene delivery products. ... Products. Resources. Pricing. Resources. Log …See details»
PeriphaGen (Herpes Drug Development Platform and …
Information on acquisition, funding, investors, and executives for PeriphaGen (Herpes Drug Development Platform and Manufacturing Expertise). Use the PitchBook Platform to explore …See details»
Periphagen - Overview, News & Similar companies | ZoomInfo.com
Oct 22, 2018 Krystal Biotech Announces Settlement with PeriphaGen, Inc. PITTSBURGH, March 15, 2022 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc., (“Krystal”) (NASDAQ: KRYS), …See details»
CONTACT US - periphagen
PeriphaGen, Inc. 2403 Sidney Street. Suite 255 Pittsburgh, PA 15203 . Success! Message received. Send. PeriphaGen is interested in speaking with potential corporate (pharma) …See details»
PeriphaGen Holdings - VentureRadar
Periphagen is a biopharmaceutical company focused on the development of herpes simplex virus type I (HSV-1) as a gene therapy vector. Our primary focus is the use of HSV-1 vectors for …See details»
PeriphaGen - Crunchbase
PeriphaGen is a biopharmaceutical company whose corporate objective is the development of first in class neuronal gene delivery products. Search Crunchbase. Start Free Trial . Chrome …See details»
Krystal Biotech Announces Settlement with PeriphaGen, Inc.
PITTSBURGH, March 15, 2022 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc., (“Krystal”) (NASDAQ: KRYS), the leader in redosable gene therapies for rare diseases, today announced …See details»
Krystal Biotech Announces Settlement with PeriphaGen, Inc.
PITTSBURGH, March 15, 2022 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc., (“Krystal”) (NASDAQ: KRYS), the leader in redosable gene therapies for rare diseases, today announced …See details»
OUR TECHNOLOGY - periphagen
PeriphaGen is a biopharmaceutical company focused on peripheral nerve gene therapy and committed to the development of innovative products for difficult-to-treat neurological …See details»
PeriphaGen - Tech Stack, Apps, Patents & Trademarks - Crunchbase
PeriphaGen is a biopharmaceutical company whose corporate objective is the development of first in class neuronal gene delivery products. Search Crunchbase. Start Free Trial . Chrome …See details»
NEWS - periphagen
In addition, Candel acquired PeriphaGen’s lead product candidate developed to address chemotherapy induced peripheral neuropathy. This product candidate has been rationally …See details»
OUR PIPELINE - periphagen
PeriphaGen’s NET vector technology allows for targeted delivery to specific sensory nerves via a simple intradermal skin injection, thus our lead products have focused on treating peripheral …See details»
Krystal Biotech Announces Settlement with PeriphaGen, Inc.
Mar 15, 2022 The settlement contains no admission of liability or wrongdoing and includes a full release of the claims made against Krystal Biotech, Inc., Krish Krishnan, Suma Krishnan, …See details»